Alterity Therapeutics's quarterly market cap
declined
from Jun. 2023 ($11.35 Mil) to Sep. 2023 ($0.00 Mil) but then
stayed the same
from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).
Alterity Therapeutics's annual market cap
declined
from Jun. 2021 ($45.15 Mil) to Jun. 2022 ($24.52 Mil) and
declined
from Jun. 2022 ($24.52 Mil) to Jun. 2023 ($11.35 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alterity Therapeutics's Enterprise Value for Today is $17.69 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Alterity Therapeutics's Market Cap
For the Biotechnology subindustry, Alterity Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alterity Therapeutics's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Alterity Therapeutics's Market Cap falls into.
Alterity Therapeutics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Alterity Therapeutics's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alterity Therapeutics (NAS:ATHE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Alterity Therapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of Alterity Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Alterity Therapeutics (Alterity Therapeutics) Business Description
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATHE has been successfully added to your 